![[STO Spotlight] Unedited Paolo Tarantino on Immune, Genetic, TILs as predictors for TNBC outcomes](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:fptm2gxhu5ik4zs4apgth6kv/bafkreifv6mr6iugypfbnxc63t4ocjqsw7ahrbo7i3z4au32f6667bbqnfm)
Data on predictors of outcome in triple negative #breastcancer with @ptarantinomd.bsky.social from @dfcibreastonc.bsky.social at @ascocancer.bsky.social with #RevealGenomics youtu.be/-RD5VjFqgUw #P2PMD #ShortTakesInOncology
Delighted to attend DEFINITIVE Consortium meeting in Barcelona in advance of study activation @cancerresearch-ucc.bsky.social @ucc.bsky.social #UCCCTG
Thanks to #SOLTI #ClinicBarcelona #RevealGenomics
Individualising therapy for HER2+ breast cancer
www.thedefinitivetrial.eu
